HomePRLD • NASDAQ
add
Prelude Therapeutics Inc
Previous close
$1.31
Day range
$1.16 - $1.35
Year range
$0.61 - $1.96
Market cap
67.35M USD
Avg Volume
253.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 32.19M | -13.37% |
Net income | -31.23M | 10.10% |
Net profit margin | — | — |
Earnings per share | -0.41 | 10.87% |
EBITDA | -31.76M | 13.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 73.22M | -59.29% |
Total assets | 114.92M | -48.76% |
Total liabilities | 39.08M | -6.99% |
Total equity | 75.84M | — |
Shares outstanding | 76.13M | — |
Price to book | 1.31 | — |
Return on assets | -62.84% | — |
Return on capital | -74.92% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -31.23M | 10.10% |
Cash from operations | -26.08M | -13.09% |
Cash from investing | 11.52M | -55.89% |
Cash from financing | 37.00K | -37.29% |
Net change in cash | -14.52M | -565.14% |
Free cash flow | -15.16M | -33.90% |
About
Founded
2016
Headquarters
Website
Employees
131
